Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 15639680

Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet
Publication date
2005 Jan 1-7
First author
Howell A

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet. 2005 Apr 2-8;365(9466):1225; author reply 1225-6. doi: 10.1016/S0140-6736(05)74802-9.
    note
    Source null
    related pmid
    15811447
    relationship
    Comment in
  2. citation
    Lancet. 2005 Apr 2-8;365(9466):1225; author reply 1225-6. doi: 10.1016/S0140-6736(05)74801-7.
    note
    Source null
    related pmid
    15811448
    relationship
    Comment in

Authors and identifiers

  1. name
    Howell A
    type
    Author
  2. name
    Cuzick J
    type
    Author
  3. name
    Baum M
    type
    Author
  4. name
    Buzdar A
    type
    Author
  5. name
    Dowsett M
    type
    Author
  6. name
    Forbes JF
    type
    Author
  7. name
    Hoctin-Boes G
    type
    Author
  8. name
    Houghton J
    type
    Author
  9. name
    Locker GY
    type
    Author
  10. name
    Tobias JS
    type
    Author
  11. name
    ATAC Trialists' Group
    type
    CollectiveName
Complete bibliographic record and source provenance
authors
  1. name
    Howell A
    type
    Author
  2. name
    Cuzick J
    type
    Author
  3. name
    Baum M
    type
    Author
  4. name
    Buzdar A
    type
    Author
  5. name
    Dowsett M
    type
    Author
  6. name
    Forbes JF
    type
    Author
  7. name
    Hoctin-Boes G
    type
    Author
  8. name
    Houghton J
    type
    Author
  9. name
    Locker GY
    type
    Author
  10. name
    Tobias JS
    type
    Author
  11. name
    ATAC Trialists' Group
    type
    CollectiveName
bibliography ids
  1. nci-bib-43cbe157300200dcac123654
book metadata
content sha256
f6de0a5c6f48a1bf1b01b9b1ee34032639f2debd41d3f1a3b738b18f20a4d793
document type
citation
dois
  1. 10.1016/S0140-6736(04)17666-6
electronic publication date
display
Source null
precision
missing
year
Source null
evidence scope
bibliographic_metadata_only
id
pubmed:15639680
immutable id
pubmed:15639680@f6de0a5c6f48a1bf1b01b9b1ee34032639f2debd41d3f1a3b738b18f20a4d793
journal
abbreviation
Lancet
issn electronic
1474-547X
issn print
0140-6736
issue
9453
name
Lancet (London, England)
nlm unique id
2985213R
pages
60-2
volume
365
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet. 2005 Apr 2-8;365(9466):1225; author reply 1225-6. doi: 10.1016/S0140-6736(05)74802-9.
    note
    Source null
    related pmid
    15811447
    relationship
    Comment in
  2. citation
    Lancet. 2005 Apr 2-8;365(9466):1225; author reply 1225-6. doi: 10.1016/S0140-6736(05)74801-7.
    note
    Source null
    related pmid
    15811448
    relationship
    Comment in
outcomes validated
false
pmid
15639680
provenance
batch id
97b9e848a139d5f8d462
provider
NCBI PubMed ESummary
record sha256
060f022f2a4fc5f89b0435753f50fd0ecec6fd84a2285bed39b72ceb5abea50e
response sha256
a316b1e9f1b120fc4a41adaaf2b205cc00afcf76d9a093a7cfa9ed2743d05be8
retrieved at
2026-09-09T23:45:57.930512+00:00
publication date
display
2005 Jan 1-7
precision
range_or_season
year
2005
publication types
  1. Comparative Study
  2. Journal Article
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/15639680/
title
Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer.

Preserved source evidence · Not medical advice